Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

High serum vaspin concentrations in patients with ulcerative colitis.

Morisaki T, Takeshima F, Fukuda H, Matsushima K, Akazawa Y, Yamaguchi N, Ohnita K, Isomoto H, Takeshita H, Sawai T, Fujita F, Nakao K.

Dig Dis Sci. 2014 Feb;59(2):315-21. doi: 10.1007/s10620-013-2905-5. Epub 2013 Oct 29.

PMID:
24166663
2.

Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.

Nikolaus S, Schulte B, Al-Massad N, Thieme F, Schulte DM, Bethge J, Rehman A, Tran F, Aden K, Häsler R, Moll N, Schütze G, Schwarz MJ, Waetzig GH, Rosenstiel P, Krawczak M, Szymczak S, Schreiber S.

Gastroenterology. 2017 Dec;153(6):1504-1516.e2. doi: 10.1053/j.gastro.2017.08.028. Epub 2017 Aug 19.

3.

Serum adipokines in inflammatory bowel disease.

Waluga M, Hartleb M, Boryczka G, Kukla M, Zwirska-Korczala K.

World J Gastroenterol. 2014 Jun 14;20(22):6912-7. doi: 10.3748/wjg.v20.i22.6912.

4.

Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease.

Weigert J, Obermeier F, Neumeier M, Wanninger J, Filarsky M, Bauer S, Aslanidis C, Rogler G, Ott C, Schäffler A, Schölmerich J, Buechler C.

Inflamm Bowel Dis. 2010 Apr;16(4):630-7. doi: 10.1002/ibd.21091.

5.

The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.

Ono Y, Kanmura S, Morinaga Y, Oda K, Kawabata K, Arima S, Sasaki F, Nasu Y, Tanoue S, Hashimoto S, Taguchi H, Uto H, Tsubouchi H, Ido A.

BMC Gastroenterol. 2017 Mar 11;17(1):40. doi: 10.1186/s12876-017-0591-z.

6.

Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.

Dawiskiba T, Deja S, Mulak A, Ząbek A, Jawień E, Pawełka D, Banasik M, Mastalerz-Migas A, Balcerzak W, Kaliszewski K, Skóra J, Barć P, Korta K, Pormańczuk K, Szyber P, Litarski A, Młynarz P.

World J Gastroenterol. 2014 Jan 7;20(1):163-74. doi: 10.3748/wjg.v20.i1.163.

7.

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease.

Yin J, Hou P, Wu Z, Nie Y.

Med Sci Monit. 2015 Jan 10;21:118-22. doi: 10.12659/MSM.892081.

8.

Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.

Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA.

Inflamm Bowel Dis. 2006 Feb;12(2):100-5.

PMID:
16432373
9.

Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease.

Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J.

Gut. 2003 Jun;52(6):847-53.

10.

Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.

Boga S, Alkim H, Koksal AR, Ozagari AA, Bayram M, Tekin Neijmann S, Sen I, Alkim C.

J Investig Med. 2016 Jun;64(5):1016-24. doi: 10.1136/jim-2016-000062. Epub 2016 Mar 21.

PMID:
27001944
11.

Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.

Kapsoritakis AN, Kapsoritaki AI, Davidi IP, Lotis VD, Manolakis AC, Mylonis PI, Theodoridou AT, Germenis AE, Potamianos SP.

BMC Gastroenterol. 2008 Nov 26;8:55. doi: 10.1186/1471-230X-8-55.

12.

Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease.

Terzoudis S, Malliaraki N, Damilakis J, Dimitriadou DA, Zavos C, Koutroubakis IE.

Eur J Gastroenterol Hepatol. 2016 Jul;28(7):814-9. doi: 10.1097/MEG.0000000000000617.

PMID:
26934527
13.

Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?

Kaplan M, Yuksel M, Ates I, Kilic ZM, Kilic H, Kuzu UB, Kayacetin E.

J Gastroenterol Hepatol. 2016 Jun;31(6):1120-5. doi: 10.1111/jgh.13254.

PMID:
26642816
14.

Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.

Stallhofer J, Friedrich M, Konrad-Zerna A, Wetzke M, Lohse P, Glas J, Tillack-Schreiber C, Schnitzler F, Beigel F, Brand S.

Inflamm Bowel Dis. 2015 Oct;21(10):2327-40. doi: 10.1097/MIB.0000000000000515.

PMID:
26263469
15.

Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.

Saadah OI, Al-Harthi SE, Al-Mughales JA, Bin-Taleb YY, Baeshen RS.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):16000-6. eCollection 2015.

16.

Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.

Sipeki N, Davida L, Palyu E, Altorjay I, Harsfalvi J, Szalmas PA, Szabo Z, Veres G, Shums Z, Norman GL, Lakatos PL, Papp M.

World J Gastroenterol. 2015 Jun 14;21(22):6952-64. doi: 10.3748/wjg.v21.i22.6952.

17.

Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease.

Yılmaz B, Köklü S, Yüksel O, Arslan S.

World J Gastroenterol. 2014 Aug 21;20(31):10916-20. doi: 10.3748/wjg.v20.i31.10916.

18.

B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.

Zhang P, Liu X, Guo A, Xiong J, Fu Y, Zou K.

Dig Dis Sci. 2016 Sep;61(9):2608-18. doi: 10.1007/s10620-016-4136-z. Epub 2016 Apr 7.

PMID:
27056038
19.

Soluble ST2: a new and promising activity marker in ulcerative colitis.

Díaz-Jiménez D, Núñez LE, Beltrán CJ, Candia E, Suazo C, Alvarez-Lobos M, González MJ, Hermoso MA, Quera R.

World J Gastroenterol. 2011 May 7;17(17):2181-90. doi: 10.3748/wjg.v17.i17.2181.

20.

Serum angiogenin in inflammatory bowel disease.

Koutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, Kouroumalis EA.

Dig Dis Sci. 2004 Nov-Dec;49(11-12):1758-62.

PMID:
15628698

Supplemental Content

Support Center